# Bluesight

Bluesight is an Asset Manager based in Washington, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Washington, United States
- **Region:** North America
- **Address:** Washington, United States
- **Founded:** 2012
- **Assets under management:** Undisclosed
- **Website:** bluesight.com
- **LinkedIn:** https://www.linkedin.com/company/bluesight-inc

## Regulatory record

- **Reports private funds:** No

## About

Bluesight, headquartered in Alexandria, United States, was established in 2011. The company develops medication management solutions utilizing RFID technology to track inventory, minimize waste, and optimize costs. Bluesight has secured $42.9 million in total funding.

## Sectors

- Digital Health
- Healthcare Services

## People

- Kevin MacDonald — Co-Founder & CEO

## Questions

### Who runs investment decisions at Bluesight?

Bluesight is an operating company, not an investment firm. Strategic and capital allocation decisions are led by co-founder and CEO Kevin MacDonald, who has guided the company since 2012. Venture capital investors including Baird Capital and Blue Heron Capital hold board seats but do not manage the firm's operations.

### How does Bluesight source proprietary deal flow?

Bluesight does not source investment deal flow. It generates revenue through enterprise software sales to hospital systems. Its acquisitions—such as the 2023 Medacist purchase and a 2020 buy of an RFID tag provider—address product gaps identified through existing hospital customer relationships.

### What investment stages does Bluesight typically target?

Bluesight itself is the target of venture investment, not an investor deploying capital into other companies. Its own fundraising history includes early-stage venture rounds, including a Series A from Baird Capital and a subsequent growth round. The firm does not participate in external investment activity.

### Which sectors does Bluesight explicitly avoid?

Bluesight operates exclusively within hospital pharmacy compliance and medication management. It has no product lines in payer analytics, electronic health records, telemedicine, or consumer health. The firm's acquisitions reinforce this narrow hospital-pharmacy focus rather than expanding into adjacent healthcare verticals.

## Related profiles

- [Serhant](https://altss.com/profile/serhant-real-estate)
- [William Taylor Nominees](https://altss.com/profile/william-taylor-nominees)

---

Last updated: 2026-06-28T01:55:30.063Z

Canonical page: https://altss.com/profile/bluesight

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology